Blood antibody screen
Facility: Ascension Via Christi Hospital Manhattan, Inc
Billing Code: 86850 (CPT)
- CPT Billing Code: 86850
- Insurance Median: $49
- Cash Discount Price: $44
- vs. Medicare Baseline: 0.92x Medicare
Average discount available for prompt cash payment at this facility.
Median negotiated contract rate across all mapped commercial carriers.
Standard federal government reimbursement rate for this code.
Visual Cost Comparison vs. Medicare
Understanding this gauge: We use the federal Medicare rate of $53.24 as the cost baseline. Rates below the baseline represent excellent value. In-network commercial rates commonly hover around 150% - 250% of Medicare, while rates exceeding 300% are elevated. Hover over the green and blue markers to view detailed calculations.
Out-of-Pocket Cost Estimator
Estimate whether it is more economical to use your insurance or pay the upfront self-pay cash rate.
Commercial Insurance Negotiated Rates
Negotiated contract ranges established by major commercial carriers at this facility.
| Carrier / Plan Group | Contract Rate Range | vs. Medicare Reference |
|---|---|---|
| Smarthealth | $7 - $69 | 13% |
| UnitedHealthcare | $8 - $138 | 15% |
| Medicaid / KanCare | $9 | 17% |
| Aetna | $9 | 17% |
| Providrs Care | $10 | 19% |
| Tricare | $18 | 34% |
| Humana | $49 - $50 | 92% |
| Va | $49 | 92% |
| Medicare (plans) | $49 - $50 | 92% |
| Ambetter / Centene | $84 | 158% |
| Blue Cross Blue Shield | $88 - $100 | 165% |
Consumer Guidance & Cost Commentary
For the CPT code 86850, representing a blood antibody screen, Ascension Via Christi Hospital Manhattan, Inc. lists a cash median price of $44.00, which is lower than the facility's negotiated rates of $49.00. While the facility's gross charge is $111.00, commercial payers negotiate rates that generally fall between $7.00 and $100.00 depending on the insurer, with UnitedHealthcare and Blue Cross Blue Shield representing the widest range at $8.00 to $100.00. It is important to note that cash-pay options can sometimes be more cost-effective for patients with high-deductible plans if the insurance negotiated rate exceeds the cash price, though this facility's negotiated rate is only slightly higher than the cash option. Patients should verify their specific plan's allowed amount before scheduling, as in-network rates vary significantly by carrier, and should inquire about self-pay or prompt-pay discounts to potentially reduce the final balance.
The facility's pricing is benchmarked against the Medicare rate of $53.24, which serves as a federal cost baseline for healthcare delivery. The facility's cash price of $44.00 is below the Medicare amount, suggesting a competitive rate relative to the government standard, whereas the median negotiated rate of $49.00 remains close to the Medicare benchmark. This data reflects the facility's status as a voluntary non-profit acute care hospital in Manhattan, Kansas, where pricing is influenced by state and local market dynamics. Consumers are advised to request an itemized billing audit if they receive a summary bill, as over 80% of hospital invoices contain errors